Last updated: April 25, 2026
What suppliers manufacture and supply MINOCIN (minocycline) and its label-grade materials?
MINOCIN is the brand name for minocycline (an oral and topical tetracycline-class antibiotic). In the U.S., product supply for MINOCIN is driven by (1) API manufacturing and API distribution, (2) formulation/finished-dose manufacturing, and (3) labeling and packaging.
Because “MINOCIN” is marketed in multiple strengths and dosage forms and changes hands across label owners and authorized manufacturers, supplier coverage depends on the exact presentation (e.g., capsules vs tablets vs topical products). No supplier list can be made complete and correct without anchoring to the exact MINOCIN NDC(s) and dosage form(s).
Which MINOCIN presentations have trackable supplier chains?
For a supplier map that is defensible for R&D or investment, the chain must be tied to specific NDCs and the current FDA listing (labeler, manufacturer, and repackager). Supplier lists for “MINOCIN” alone (without NDC) are not complete.
Below are the supplier-chain entities that typically appear in FDA drug listing records for minocycline finished-dose products:
| Supplier-chain node |
What it does |
Where it shows up in records |
| Finished-dose manufacturer (FDF) |
Manufactures tablets/capsules per label |
FDA “Manufacturers/Labelers” for the specific NDC |
| Repackager/secondary distributor |
Performs packaging, labeling, or repack |
FDA listing fields tied to NDC |
| API manufacturer (API) |
Produces minocycline API used by FDF |
Typically in DMFs (where referenced) or in commercial supplier catalogs |
| API distributor |
Supplies API to FDF manufacturers |
Commercial supply chain (not always public) |
| Packaging supplier |
Provides packaging components |
Usually not public unless tied to labeler contracts |
Who supplies minocycline API used by MINOCIN?
Public, auditable identification of minocycline API suppliers requires API-to-product linkage (DMF cross-references) or direct labeler/manufacturer disclosures per NDC. A standalone “minocycline API suppliers” list cannot be made complete for MINOCIN without product-specific linkage.
Who manufactures MINOCIN finished doses (capsules/tablets) by NDC?
Same constraint: supplier identification must be tied to the finished-dose manufacturer(s) listed for the specific MINOCIN NDC(s). Without NDC, the manufacturer set can mix multiple sites and labelers across time.
How to use MINOCIN supplier data for diligence (what to extract from authoritative sources)
To produce a defensible “supplier list” for MINOCIN, diligence normally extracts the following per exact NDC:
- Labeler (marketing authorization holder for that NDC)
- Manufacturer name and site (finished-dose manufacturing site)
- Repackager (if present)
- Submission history that indicates changes in manufacturing and labeler responsibility
- For API: DMF references tied to the approved product (where discoverable via public DMF index entries and cross-references)
Key Takeaways
- “MINOCIN” is a brand for minocycline, but supplier identification must be tied to the specific dosage form and NDC to be accurate.
- Supplier chains split into finished-dose manufacturers and API suppliers, and only the finished-dose chain is consistently visible in public FDA product listings.
- A complete supplier list for “MINOCIN” cannot be generated accurately without anchoring to the exact NDC(s).
FAQs
-
Are minocycline API suppliers the same as MINOCIN finished-dose manufacturers?
No. API suppliers manufacture minocycline active ingredient; finished-dose manufacturers formulate and package the specific MINOCIN presentation.
-
Where can finished-dose supplier information be confirmed publicly?
In FDA drug product listing data for the exact MINOCIN NDC.
-
Do minocycline API suppliers vary by manufacturer site and time period?
Yes. Labelers and finished-dose manufacturers can change API sources and manufacturing sites across approvals and manufacturing changes.
-
Can one supplier list cover all MINOCIN strengths and dosage forms?
No. Supplier responsibility can differ across capsules versus tablets and across strengths.
-
What is the minimum data needed to map MINOCIN suppliers precisely?
The exact MINOCIN dosage form and NDC(s) to extract labeler/manufacturer/repackager from FDA records.
References
[1] U.S. Food and Drug Administration. Drug Product Database (NDC Directory / Drugs@FDA listing information). FDA. https://www.accessdata.fda.gov/scripts/cder/daf/
